Branded Wegovy may be covered by some commercial insurance plans for patients meeting BMI and comorbidity criteria, but coverage is inconsistent
The patient may have acute telogen effluvium, chronic telogen effluvium, androgenetic alopecia, female-pattern hair loss, or telogen effluvium superimposed on pre-existing pattern loss
If symptoms of CTS appear, it is important to discuss them with a healthcare provider
Choosing between these platforms ultimately depends on personal priorities: whether you value telemedicine convenience (Mochi, Remedy Meds), compounded flexibility and sourcing transparency (PlexusDx), or genetic pathway context for clinical conversations
Endocrinology 127 (5), 22172222